Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57,709,383
-
Total 13F shares
-
42,084,293
-
Share change
-
+2,026,575
-
Total reported value
-
$714,575,662
-
Put/Call ratio
-
84%
-
Price per share
-
$16.98
-
Number of holders
-
161
-
Value change
-
+$79,096,714
-
Number of buys
-
124
-
Number of sells
-
51
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q2 2015
As of 30 Jun 2015,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,084,293 shares.
The largest 10 holders included
NEA Management Company, LLC, BlackRock Fund Advisors, Murphy Michael R, Invesco Ltd., Ranger Investment Management, L.P., Apex Capital Management, VANGUARD GROUP INC, Ameriprise Financial Inc, PRICE T ROWE ASSOCIATES INC /MD/, and KOPP INVESTMENT ADVISORS LLC.
This page lists
161
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.